Neuroblastomas are the most common cancer in infants, with about 700–800 diagnoses per year in the US, according to the American Cancer...

Despite advances in treatment, survival rates for high-risk and relapsed/refractory neuroblastoma remain dismal, and options like...

The survival rate for children with a rare but deadly cancer could one day be improved by adding an existing drug—which is currently used...

Giselle Saulnier Sholler has spent 20 years working treatments for neuroblastoma, a particularly aggressive form of early childhood...

Researchers from Karolinska Institutet have made a significant breakthrough in the study of childhood neuroblastoma, a type of cancer...

Researchers in Italy and Australia report a triple combination strategy involving CRISPR that boosts the response of neuroblastoma to...

Running a clinical trial requires enough patient participants to gather robust data so that researchers can draw appropriate conclusions...

The FDA has granted a second orphan drug designation to opaganib in oncology, this time for patients with neuroblastoma. Read more:...

Scientists and clinicians at St. Jude Children’s Research Hospital identified the genetic vulnerability BARD1 in a patient with pediatric...

The study marks the first time that researchers identified malignant cells responsible for relapse in neuroblastoma and offers insights...